Angelman syndrome has been cured multiple ways in mice, and the progress our scientists are making is nothing short of thrilling.
[/one-half]
[one-half]
YOU ARE NOT ALONE.
We are all parents of children with Angelman syndrome, and we’re standing by to answer questions and assist you.
[/one-half]
[/second-section]
[divider-dna]
[third-section]
Angelman syndrome (AS) is a rare neurogenetic disorder that affects approximately one in 15,000 people – about 500,000 individuals worldwide. Symptoms typically include difficulty suckling and eating, gastrointestinal issues, delayed crawling and babbling, balance and motor impairment, and seizures.
[one-third]
[/one-third]
[one-third]
[/one-third]
[one-third]
[/one-third]
[/third-section]
[fourth-section]
[half-half-container]
[/half-half-container]
Our sole mission is to cure Angelman syndrome. That’s why FAST brought together a multidisciplinary team of more than two-dozen scientists from top research universities and pharmaceutical companies. These men and women are the nation’s foremost authorities on Angelman syndrome (AS), and they have joined forces on a focused path to a cure.
[/fourth-section]
[fifth-section]
Connect with other people who have a child or loved one with Angelman syndrome.
[one-fourth]
[/one-fourth]
[one-fourth]
[/one-fourth]
[one-fourth]
[/one-fourth]
[one-fourth]
[/one-fourth]
[/fifth-section]